COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 2495: Articles 24941-24950  | Next

An Optimization Framework to Study the Balance Between Expected Fatalities due to COVID-19 and the Reopening of U.S. Communities
Chen, V. C. P., Zhou, Y., Fallahi, A., Viswanatha, A., Ghasemi, Y., Ohol, N. S., Rosenberger, J. M., Liu, F., Ju, X., Guild, J. B.
10.1101/2020.07.16.20152033 — Posted: 2020-07-20
Providing breastfeeding support during the COVID-19 pandemic: Concerns of mothers who contacted the Australian Breastfeeding Association
Hull, N., Kam, R. L., Gribble, K. D.
10.1101/2020.07.18.20152256 — Posted: 2020-07-20
Epidemiological Profile and Transmission Dynamics of COVID-19 in the Philippines
Haw, N. J. L., Uy, J., Sy, K. T. L.
10.1101/2020.07.15.20154336 — Posted: 2020-07-20
Genetic validation of the use of tocilizumab, statins and dexamethasone in COVID-19
Schooling, C. M., Au Yeung, S., Kwok, M., Zhao, J.
10.1101/2020.07.09.20149450 — Posted: 2020-07-20
Evaluation of efficiency and sensitivity of 1D and 2D sample pooling strategies for diagnostic screening purposes
Verwilt, J., Mestdagh, P., Vandesompele, J.
10.1101/2020.07.17.20152702 — Posted: 2020-07-20
Dynamics and significance of the antibody response to SARS-CoV-2 infection
Iyer, A. S., Jones, F. K., Nodoushania, A., Kelly, M., Becker, M., Slater, D., Mills, R., Teng, E., Kamruzzaman, M., Garcia-Beltran, W. F., Astudillo, M., Yang, D., Miller, T. E., Oiver, E., Fischinger, S., Atyeo, C., Iafrate, A. J., Calderwood, S. B., Lauer, S. A., Yu, J., Li, Z., Feldman, J., Hauser, B. M., Cardonna, T. M., Branda, J. A., Turbett, S. E., LaRocque, R. C., Mellon, G., Barouch, D. H., Schmidt, A. G., Azman, A. S., Alter, G., Ryan, E. T., Harris, J. B., Charles, R. C.
10.1101/2020.07.18.20155374 — Posted: 2020-07-20 Discussion: Onsite | Offsite
Observational Study of Haloperidol in Hospitalized Patients with Covid-19
HOERTEL, N., SANCHEZ RICO, M., VERNET, R., JANNOT, A.-S., NEURAZ, A., BLANCO, C., LEMOGNE, C., AIRAGNES, G., PARIS, N., DANIEL, C., GRAMFORT, A., LEMAITRE, G., BERNAUX, M., BELLAMINE, A., BEEKER, N., LIMOSIN, F.
10.1101/2020.07.15.20150490 — Posted: 2020-07-20
COVID-19, Race, and Redlining
Bertocchi, G., Dimico, A.
10.1101/2020.07.11.20148486 — Posted: 2020-07-20
A privacy-preserving Bayesian network model for personalised COVID19 risk assessment and contact tracing
Fenton, N., McLachlan, S., Lucas, P., Dube, K., Hitman, G., Osman, M., Kyrimi, E., Neil, M.
10.1101/2020.07.15.20154286 — Posted: 2020-07-19
An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19
McGregor, R., Chauss, D., Freiwald, T., Yan, B., Wang, L., Nova-Lamperti, E., Zhang, Z., Teague, H., West, E., Bibby, J., Kelly, A., Malik, A., Freeman, A., Schwartz, D., Portilla, D., John, S., Lavender, P., Lionakis, M. S., Mehta, N. N., Kemper, C., Cooper, N., Lombardi, G., Laurence, A., Kazemian, M., Afzali, B.
10.1101/2020.07.18.210161 — Posted: 2020-07-19 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).